What is Knowledge Synthesis?
Knowledge Synthesis Inc. is at the forefront of accelerating medical discovery through the sophisticated integration and analysis of extensive experimental data across diverse biological contexts. The company provides bespoke data analysis, discovery research, and advanced technology solutions, aiming to significantly enhance the return on investment for life sciences researchers. Their proprietary platform, iDataMed, empowers researchers to navigate complex Big Data landscapes, thereby facilitating the identification of crucial biomolecular findings. The core mission of Knowledge Synthesis is to offer comprehensive insights into cellular mechanisms, model systems, and clinical samples, ultimately driving more informed decision-making in the medical field.
How much funding has Knowledge Synthesis raised?
Knowledge Synthesis has raised a total of $28K across 1 funding round:
Debt
$28K
Debt (2021): $28K with participation from PPP
What's next for Knowledge Synthesis?
Positioned at a significant Series B/C stage, Knowledge Synthesis's recent substantial expansion capital infusion is poised to fuel strategic growth initiatives. This investment will likely be directed towards scaling operations, enhancing the capabilities of the iDataMed platform, and broadening market reach within the life sciences sector. The company's focus on integrating and analyzing large-scale experimental data suggests a trajectory towards becoming a pivotal player in data-driven medical research and development.
See full Knowledge Synthesis company page
